Quarterly report pursuant to Section 13 or 15(d)

Mortgage Notes Payable and Lines of Credit

v2.4.0.6
Mortgage Notes Payable and Lines of Credit
3 Months Ended
Mar. 31, 2013
Mortgage Notes Payable and Lines of Credit [Abstract]  
MORTGAGE NOTES PAYABLE AND LINES OF CREDIT

NOTE 6. MORTGAGE NOTES PAYABLE AND LINES OF CREDIT

Our mortgage notes payable and line of credit as of March 31, 2013, and December 31, 2012, are summarized below:

 

                                                                             
                          As of March 31, 2013     As of December 31, 2012  

Issuer

 

Type of
Issuance

  Date of
Issuance
    Initial
Commitment
    Maturity
Date
    Principal
Outstanding
    Stated
Interest Rate
    Remaining
Availability
    Principal
Outstanding
    Stated
Interest
Rate
    Remaining
Availability
 
MetLife  

Mortgage Note Payable

    12/30/2010       45,200,000       1/5/2026     $ 29,489,165       3.50   $ 13,565,000     $ 30,717,880       3.50   $ 13,565,000  
MetLife  

Line of Credit

    5/31/2012       4,785,000       4/5/2017       100,000       3.31     4,685,000       100,000       3.35     4,685,000  
                               

 

 

           

 

 

   

 

 

           

 

 

 
                          Totals:     $ 29,589,165             $ 18,250,000     $ 30,817,880             $ 18,250,000  
                               

 

 

           

 

 

   

 

 

           

 

 

 

 

(1)

Our line of credit with RaboBank was repaid, in full, in May 2012 and was terminated at such time. No early termination fee was incurred; however, $36,031 of unamortized deferred financing costs were written off to interest expense upon the termination.

The weighted-average effective interest rate charged on all of our borrowings for the three months ended March 31, 2013 and 2012, excluding the impact of deferred financing costs, was 3.62% and 3.65%, respectively.

Mortgage Note Payable

On December 30, 2010, we executed a loan agreement with MetLife in an amount not to exceed $45.2 million, pursuant to a long-term note payable. The note currently accrues interest at a rate of 3.50% per year, and the interest rate is subject to adjustment on January 5, 2014, and every three years thereafter to then-current market rates. The note is scheduled to mature on January 5, 2026, and we may not repay the note prior to maturity, except on one of the four interest rate adjustment dates. The loan originally provided for three disbursements, which were drawn in 2011, and was amended in December 2011 to provide for three additional disbursements, two of which were drawn prior to the December 2012 amendment. In connection with the December 2011 amendment, we also incur a commitment fee of 0.20% on undrawn amounts, effective January 5, 2012. As amended in December 2012, the loan agreement provides for up to three future disbursements by December 2013, none of which have been drawn to date.

As of March 31, 2013, $29.5 million was outstanding under this loan. The remaining three disbursements may not exceed $13.6 million, in aggregate, and must be used solely to fund acquisitions of new property. The interest rate for future disbursements will be based on prevailing market rates, and at the time of such disbursements, the interest rate on the loan will adjust to reflect the rate on the new disbursement blended with the existing rate on the then-outstanding loan amount. If we have not drawn such funds for the acquisition of new properties by December 14, 2013, MetLife has the option to be relieved of its obligation to disburse the additional funds to us under this loan.

The fair value of the mortgage note payable is valued using Level 3 inputs under the hierarchy established by ASC 820, “Fair Value Measurement and Disclosure,” and is calculated based on a discounted cash flow analysis, using interest rates based on management’s estimates of market interest rates on long-term debt with comparable terms. As of March 31, 2013, and December 31, 2012, the fair value of the mortgage note payable was $29.5 million and $30.7 million, respectively, both of which equaled the carrying values at each date. At both March 31, 2013 and December 31, 2012, the interest rates on the mortgage note payable were deemed to be at market rates, and thus it was concluded that the carrying values approximated fair values.

Scheduled principal payments of the mortgage note payable for the remainder of 2013 and each of the five succeeding fiscal years and thereafter are as follows:

 

 

             

Period

  Scheduled
Principal Payments
 
For the remaining nine months ending December 31:   2013   $ —    
For the fiscal years ending December 31:   2014     1,179,567  
    2015     1,132,384  
    2016     1,087,088  
    2017     1,043,605  
    2018     1,001,861  
    Thereafter     24,044,660  
       

 

 

 
        $ 29,489,165  
       

 

 

 

All of the properties owned as of March 31, 2013, with the exception of the San Andreas Farm, have been pledged as collateral under this mortgage note payable.

Line of Credit

In November 2002, we entered into a $3.3 million revolving line of credit facility with Agrifinance (the “Prior Credit Facility”), which was scheduled to mature on December 1, 2017, secured by the San Andreas Farm. In May 2012, we repaid the outstanding balance, in full, under the Prior Credit Facility and obtained a new, $4.8 million revolving line of credit facility with MetLife that matures on April 5, 2017 (the “Credit Facility”). Our obligations under the Credit Facility are secured by a mortgage on our San Andreas Farm. The interest rate charged on the advances under the Credit Facility is equal to the three-month LIBOR in effect at the beginning of each calendar quarter plus 3.00%, with a minimum annualized rate of 3.25%. We may use advances under the Credit Facility for both general corporate purposes and the acquisition of new properties.

As of both March 31, 2013 and December 31, 2012, there was $0.1 million outstanding under the Credit Facility, which is the minimum balance required, and approximately $4.7 million of availability from which we could draw. Due to the short-term and revolving nature of a line of credit, the carrying value of our line of credit of $0.1 million at both March 31, 2013, and December 31, 2012, is deemed to approximate fair value.